drugset / Trial / NCT02723487

Ultrasound Guided Transversus Abdominis Plane Block in Pediatric Surgery

NCT02723487 ↗

Phase 2 Completed 60 enrolled Abdelrady S Ibrahim, MD
RandomizedParallel-groupDouble-blindPrevention

Summary

The primary objective of this study is to assess differences in postoperative pain experienced by pediatric patients having transversus abdominis plane block block with bupivacaine (0.125% and 0.25%) compared with control group will receive conventional iv analgesia after Laparoscopic surgery.

Timeline

Start
2016-04
Primary completion
2017-05
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.125 % Other
Comparator Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.